维普中文期刊产品整合服务
15篇 您的检索式:作者名="Mtiller RH"
    题名 作者 年代 出处 被引量
1Production and characterization of Hesperetin nanosuspensions for der- mal delivery 显示文摘Mishra PR A1 Shaal L Mtiller RH 2009Int J Pharm2009,371,12:1
2Production and characteriza- tion of antioxidant apigenin nanocrystals as a novel UV skin protective formulation 显示文摘Shaal LA Shegokar R Mtiller RH 2011Int J Pharm2011,420,1:1
3Solid lipid nanoparticles for parenteral drug delivery' 显示文摘Wissing SA Kayser O Mtiller RH 2004Adv Drug Deli '' Hey2004,56,9:1
4Nanosuspensions : a promisingformulation for the new phospholipase A2 inhibitor PX - 18显示文摘Pardeike J Mtiller RH 2010Int J Pharm2010,391,12:1
5Solid-liquid (semi-solid) liquid particles and method of producing highly concentrated lipid particle dispersions 显示文摘Mtiller RH Lippacher A Jenning V 2000in PCT / EP00 / 045652000,,:1
6Drug nanocrystals of poorly soluble drugs producedby high pressure homogenization 显示文摘Keck CM Mtiller RH 2006Eur J Pharm Biopharm2006,6,2:1
7Lipid nanoparticles for parenteral delivery of actives 显示文摘Joshi MD Mtiller RH 2009Eur J Pharm Biopharm2009,71,2:1
8Formulation of intravenous carbam- azepine emulsions by SolEmuls technology 显示文摘Akkar A Mtiller RH 2003Eur JP- harmBiopharm2003,55,3:1
9Influence of nanostru- ctured lipid carriers (NLC) on the physical properties of the Cutanova Nanorepair Q10 cream and the in vivoskin hydration effect 显示文摘Pardeike J Schwabe K Mtiller RH 2010International Journal of Pharmaceutics2010,396,12:1
10Sta:e of the art of nanocryslals- Special features, production, nanotoxicology aspects and intracellular delivery显示文摘Mtiller RH Gohla S Keck CM 2011EurJ Pharm Biopharm2011,78,1:1
11Physicochemical characterization of propofol-loaded emulsions and interaction with plasma proteins 显示文摘MtiLLER RH HARNISCH S 2000Eur Hosp Pharm2000,6,:1
12Nanosuspensions: a promising formulation for the new phospholipase A: inhibitor PX-18 显示文摘Pardeike J Mtiller RH 2010IntJPharm2010,391,12:1
13Dermal and ocular safety of the new phospholipase A2 inhibitors PX-18 and PX-13 formulated as drug nanosuspension 显示文摘Pardeike J Mtiller RH 2009J Biomed Nanotechnol2009,5,4:1
14Nanosuspensions:a promising formulation for the new phospholipase A2 inhibitor PX-18 显示文摘Pardeike J Mtiller RH 2010Int J Pharm2010,391,12:1
15Drug nanoerystals of poorly soluble drugs produced by high pressure homogenisation 显示文摘Keck CM Mtiller RH 2006Eur J Pharm Biop- harm2006,62,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费